About the Company
at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SIGA News
SIGA Technologies, Inc.'s (NASDAQ:SIGA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
SIGA Technologies' (NASDAQ:SIGA) stock is up by a considerable 34% over the past month. We wonder if and what role ...
SIGA Technologies Inc Reports Robust Financial Growth in 2023
Product Sales: Increased to $131 million in 2023, a 51% rise from 2022. Pre-Tax Operating Income: Grew to $84 million, a 96% ...
SIGA Technologies Inc SIGA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
SIGA Declares Special Cash Dividend of $0.60 Per Share
SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company ...
SIGA Technologies Inc
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats.
SIGA Technologies, Inc. (SIGA) Q4 2023 Earnings Call Transcript
Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward-looking statements made during this call are based on management's current ...
SIGA Technologies Inc.
Below is a summary of the major fundamental and technical factors we consider when determining our overall recommendation of SIGA shares. It is provided in order to give you a deeper understanding ...
Loading the latest forecasts...